Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II. [PDF]
Muenzer J +14 more
europepmc +1 more source
Clinical investigator perspectives on patient outcomes in children with neuronopathic mucopolysaccharidosis II during intrathecal idursulfase-IT treatment. [PDF]
Yee KS +4 more
europepmc +1 more source
Analysis of caregiver perspectives on patients with mucopolysaccharidosis II treated with pabinafusp alfa: results of qualitative interviews in Japan. [PDF]
Nakamura K +8 more
europepmc +1 more source
Characterization of orthopedic manifestations in patients with mucopolysaccharidosis II using data from 15 years of the Hunter Outcome Survey. [PDF]
Link B, Botha J, Giugliani R.
europepmc +1 more source
Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II. [PDF]
Yee KS +4 more
europepmc +1 more source
A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutation [PDF]
Ahmed, Alia +8 more
core +1 more source
Mucopolysaccharidosis II (Hunter's syndrome)
openaire +2 more sources
Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage. [PDF]
Catalano F +13 more
europepmc +1 more source
Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II. [PDF]
Kubaski F +18 more
europepmc +1 more source
Carpal Tunnel Syndrome in the Setting of Mucopolysaccharidosis II (Hunter Syndrome). [PDF]
Argenta AE, Davit A.
europepmc +1 more source

